2024-03-28T22:45:17Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_E73C64998C98
2024-03-23T03:08:20Z
openaire
documents
urnserval
serval:BIB_E73C64998C98
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
10.1080/2162402X.2020.1738797
000519985600001
32760603
Saulite
I.
author
Ignatova
D.
author
Chang
Y.T.
author
Fassnacht
C.
author
Dimitriou
F.
author
Varypataki
E.
author
Anzengruber
F.
author
Nägeli
M.
author
Cozzio
A.
author
Dummer
R.
author
Scarisbrick
J.
author
Pascolo
S.
author
Hoetzenecker
W.
author
Bobrowicz
M.
author
Guenova
E.
author
article
2020
Oncoimmunology
2162-4011
2162-4011
journal
9
1
1738797
Monoclonal antibody
PD-1
PD-L1
PD-L2
Sézary Syndrome
immunotherapy
leukemic cutaneous T-cell lymphoma
eng
60_published
true
peer-reviewed
Publication types: Journal Article
Publication Status: epublish
https://serval.unil.ch/notice/serval:BIB_E73C64998C98
https://serval.unil.ch/resource/serval:BIB_E73C64998C98.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E73C64998C982
Creative Commons : Attribution-NonCommercial 4.0 International